Paul Tudor Jones Travere Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 38,144 shares of TVTX stock, worth $663,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,144

Previous 37,283 2.31%

Holding current value

$663,705

Previous $306,000 74.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $6,793 - $13,095	861 Added 2.31%	38,144 $533,000
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $541 - $852	-103 Reduced 0.28%	37,283 $306,000
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $268,431 - $367,130	37,386 New	37,386 $288,000
Q3 2023 Nov 15, 2023	SELL	$7.64 - $17.25 $46,199 - $104,310	-6,047 Reduced 11.36%	47,195 $421,000
Q2 2023 Aug 14, 2023	SELL	$15.3 - $22.61 $206,978 - $305,868	-13,528 Reduced 20.26%	53,242 $817,000
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $708,630 - $910,243	39,766 Added 147.26%	66,770 $1.5 Million
Q4 2022 Feb 14, 2023	SELL	$18.47 - $26.14 $90,650 - $128,295	-4,908 Reduced 15.38%	27,004 $568,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $731,103 - $913,640	31,912 New	31,912 $786,000
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $1.75 Million - $2.5 Million	-83,437 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $494,110 - $640,396	20,928 Added 33.48%	83,437 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $140,125 - $179,445	5,757 Added 10.14%	62,509 $1.94 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $302,628 - $583,574	-23,315 Reduced 29.12%	56,752 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $1.13 Million - $2.11 Million	80,067 New	80,067 $1.17 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account